target,target_id,target_uniprot,target_species,ligand,ligand_id,ligand_species,ligand_pubchem_cid,smiles,inchi,inchikey,type,action,action_comment,endogenous,primary_target,concentration_range,affinity_parameter,affinity_high,affinity_median,affinity_low,original_affinity_units,original_affinity_low_nm,original_affinity_median_nm,original_affinity_high_nm,original_affinity_relation,assay_description,receptor_site,ligand_context,pubmed_id cytochrome b-245 beta chain,3002,P04839,Human,compound 7c [PMID: 22041175],9931,,51035721,Clc1ccccc1n1[nH]c2c(c1=O)c1CN(CCCn1c(=O)c2)Cc1ccccc1,"InChI=1S/C23H21ClN4O2/c24-17-9-4-5-10-19(17)28-23(30)22-18(25-28)13-21(29)27-12-6-11-26(15-20(22)27)14-16-7-2-1-3-8-16/h1-5,7-10,13,25H,6,11-12,14-15H2",DISVMXDWAMMVLT-UHFFFAOYSA-N,Inhibitor,Inhibition,,,,,pKi,,5.87,,Ki,,1340.0,,=,,,,22041175, cytochrome b-245 beta chain,3002,P04839,Human,setanaxib,9932,,58496428,Clc1ccccc1n1[nH]c2c(c1=O)c(c1cccc(c1)N(C)C)n(c(=O)c2)C,"InChI=1S/C21H19ClN4O2/c1-24(2)14-8-6-7-13(11-14)20-19-16(12-18(27)25(20)3)23-26(21(19)28)17-10-5-4-9-15(17)22/h4-12,23H,1-3H3",RGYQPQARIQKJKH-UHFFFAOYSA-N,Inhibitor,Inhibition,,,,,pKi,,5.76,,Ki,,1750.0,,=,,,,22806357, cytochrome b-245 beta chain,3002,P04839,Human,NSC 780521,9933,,133081973,[O-][N+](=O)c1cccc2c1c1c([I-]2)cccc1[N+](=O)[O-],InChI=1S/C12H6IN2O4/c16-14(17)9-5-1-3-7-11(9)12-8(13-7)4-2-6-10(12)15(18)19/h1-6H/q-1,NBIXKUWRZRFYBQ-UHFFFAOYSA-N,Inhibitor,Inhibition,,,,,pIC50,,5.98,,IC50,,1049.0,,=,Inhibition of PMA-induced superoxide production in human PMNs.,,,28709950, cytochrome b-245 beta chain,3002,P04839,Human,GKT136901,9935,,17027464,Clc1ccccc1n1[nH]c2c(c1=O)c(C)n(c(=O)c2)Cc1ccccn1,"InChI=1S/C19H15ClN4O2/c1-12-18-15(10-17(25)23(12)11-13-6-4-5-9-21-13)22-24(19(18)26)16-8-3-2-7-14(16)20/h2-10,22H,11H2,1H3",DNKYHHFCPXKFIY-UHFFFAOYSA-N,Inhibitor,Inhibition,,,,,pKi,,5.82,,Ki,,1530.0,,=,Cell free assay of ROS production by NOX2 membranes.,,,20942471,